1. Under what conditions are drug advertisements to the general public generally permitted?
2. Which type of research involves intervention, treatment, or medication programs using human subjects?
3. What ethical criteria should be followed for medical drug promotion?
4. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
5. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
6. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
7. Which of the following offenses punishable under Schedule-III is non-cognizable?
8. What is the maximum duration of a licence issued under Drugs Licensing, Registering & Advertising rules 1976?
9. What is the purpose of a separate application for manufacturing drugs on more than one set of premises?
10. What is the short title of the rules that govern the Drugs Appellate Board?
11. How many members does the Policy Board consist of?
12. What action should the Authority take in response to objections raised by the Auditor-General?
13. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
14. What is the purpose of the license to manufacture drugs for experimental purposes?
15. Who qualifies as a Federal Inspector according to these rules?
16. Who may physically inspect an imported consignment, draw samples, and order the importer not to sell or dispose of the drug for a specific period?
17. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
18. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
19. What is the primary function of the Federal Drug Laboratory as stated in the rules?
20. What is the role of the Appellate Board under The Drug Regulatory Authority of Pakistan Act, 2012?
21. In which situations may the Registration Board provisionally register a drug for a period of two years?
22. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
23. What condition must be met for a drug or substance to be advertised through press without reference to the Federal Government?
24. Who can revoke an order passed under Section 32 of the DRAP Act, 2012?
25. What substances are NOT included in the definition of "Drug" under Schedule-I?
26. What kind of offense is non-cognizable under the Drugs Act 1976?
27. For drugs other than those falling under specific categories, whose approval is required for the specifications?
28. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
29. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
30. When a Federal Inspector is not competent to take action under Schedule-IV, what should he do?
31. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
32. What is the duration of a license to export drugs?
33. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
34. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
35. What is the penalty for giving a false warranty in respect of any therapeutic good or applying a warranty given for another therapeutic good?
36. In which circumstances may the Registration Board register a drug on its own motion?
37. Who is considered an "investigator" under the Drugs (Research) Rules?
38. What are the conditions that the Central Licensing Board must ensure are complied with before granting or renewing a licence to manufacture drugs by way of basic or semi-basic manufacture?
39. What is the primary focus of basic research in the context of the Drugs (Research) Rules?
40. What are "Medical Devices" under Schedule-I?
41. Within what time frame should the Authority submit its annual report to the Federal Government?
42. According to the Drug Licensing, Registering & Advertisement rules 1976, what type of information should advertisements to physicians and health-related professionals be consistent with?
43. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
44. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
45. What does an Inspector require from a person during a search or seizure under Schedule-V?
46. In case an exporter's license is suspended or canceled, what recourse does the licensee have?
47. Which of the following is NOT considered as "Therapeutic goods" under the Act?
48. Which of the following statements about advertisement material is NOT true?
49. What is the maximum allowable retailer's discount for drugs?
50. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
51. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
52. Which power of the Inspector requires specific authorization by the Government?
53. When does an Inspector need to divide a sample into three portoons instead of four?
54. What form should be used for applying for the grant or renewal of a licence to manufacture drugs?
55. What is the purpose of the Central Research Fund mentioned in the Drugs Licensing, Registering & Advertising Rules 1976?
56. Under what condition can finished drugs be imported?
57. What is the purpose of an "airlock" in pharmaceutical manufacturing?
58. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
59. The Central Research Fund fee collected by the Authority will be utilized for:
60. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
61. What is the role of the Quality Control Department in the manufacturing process?
62. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
63. What is the duration of a license to import drugs, unless suspended or canceled?
64. What is the maximum quantity of a single drug that can be imported for personal use without exceeding the limit?
65. What does the term "batch number (or lot number)" refer to?
66. What are "Medicated Cosmetics" under Schedule-I?
67. Which type of ophthalmic preparations is allowed to have a preservative?
68. How often must records of quarterly production and disposal of a drug be supplied to the Chairman of the Registration Board?
69. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
70. What is the role of the Quality Control Department in the manufacturing process?
71. The Drugs Act, 1976 extends to which of the following areas?
72. What is the main duty of a Federal Inspector?
73. What are "Medical Devices" under Schedule-I?
74. What is the procedure for appealing the suspension or cancellation of a license under Drugs Import & Export Rules 1976?
75. Within what time frame should the Authority submit its annual report to the Federal Government?
76. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
77. Who has the power to institute a prosecution for a contravention of any provision of the DRAP Act, 2012, and The Drugs Act, 1976?
78. What is the definition of "Biological Drugs (Ready-to-fill form)" under Schedule-I?
79. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
80. According to the schedule in the Drugs (Specifications) Rules, what specifications should drugs bear that reference publications specified under sub-clause (ii) of clause (z) of Section 3?
81. Under what conditions is contract manufacture permissible?
82. What is the purpose of Schedule-III of the DRAP Act?
83. What authority is responsible for inspecting and regulaying the manufacturing of drugs under 1976 rules?
84. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
85. Who has the authority to establish the Drug Regulatory Authority of Pakistan?
86. What is the commencement date for the Drugs (Specifications) Rules, 1978?
87. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
88. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
89. What action should the Authority take in response to objections raised by the Auditor-General?
90. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
91. What is the purpose of the Committee on Drugs Evaluation?
92. Which of the following substances would NOT be considered a "Medicated Cosmetic"?
93. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
94. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
95. Who is responsible for maintaining records of quarterly production and disposal of a drug?
96. What information should be included in the written contract between the contract giver and contract acceptor for contract manufacture?
97. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
98. What is the purpose of 'the Drugs (Federal Inspectors, Federal Drug Laboratory and Federal Government Analysts) Rules, 1976'?
99. What is the term of office for members of the Registration Board?
100. Who serves as the ex-officio Chairman of the Appellate Board?
